# VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)

> **NCT03562494** · PHASE1 · COMPLETED · sponsor: **Neurocrine Biosciences** · enrollment: 14 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **BIOLOGICAL:** VY-AADC02
- **OTHER:** Sham (Placebo) Surgery

## Key facts

- **NCT ID:** NCT03562494
- **Lead sponsor:** Neurocrine Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-17
- **Primary completion:** 2024-10-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03562494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03562494, "VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03562494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*